Assignee
ADLAI NORTYE BIOPHARMA CO LTD
CN·6 granted patents·10 pending applications·3 citations·filing 2019–2023
Top patents by PatentIndex Score
16 records- 0180US12091398B2PD-L1 antagonist compoundADLAI NORTYE BIOPHARMA CO LTD·Filed 2020·Granted Sep 17, 2024·2 cites·29 claims
- 0278US11111230B2Indoleamine 2,3-dioxygenase inhibitors and use of same in medicineADLAI NORTYE BIOPHARMA CO LTD·Filed 2020·Granted Sep 7, 2021·1 cites·3 claims
- 0361US2025381143A1A solid pharmaceutical compositionADLAI NORTYE BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0458US2024085425A1Biomarker and application thereofADLAI NORTYE BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0555US2025163062A1Wnt pathway inhibitor compoundsADLAI NORTYE BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0654US2024043551A1Anti-tnfr2 antibody and application thereofADLAI NORTYE BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0753US11680271B2Construction of fully human antibody yeast display techniqueADLAI NORTYE BIOPHARMA CO LTD·Filed 2021·Granted Jun 20, 2023·0 cites·16 claims
- 0853US2024368147A1Cyclin k degraderADLAI NORTYE BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0953US2024285640A1Combination therapy for treating pik3ca-mutated cancerADLAI NORTYE BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1053US2025230245A1A fusion polypeptide and its useADLAI NORTYE BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1152US11965875B2System and method for screening and assessing agents for tumor immunotherapyADLAI NORTYE BIOPHARMA CO LTD·Filed 2021·Granted Apr 23, 2024·0 cites·9 claims
- 1249US2023399327A1High activity hpk1 kinase inhibitorADLAI NORTYE BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1349US2023390301A1High-activity wnt pathway inhibitor compoundADLAI NORTYE BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1447US12583839B2PD-L1 antagonist compoundADLAI NORTYE BIOPHARMA CO LTD·Filed 2020·Granted Mar 24, 2026·0 cites·19 claims
- 1540US12364702B2Highly active sting protein agonist compoundADLAI NORTYE BIOPHARMA CO LTD·Filed 2019·Granted Jul 22, 2025·0 cites·13 claims
- 1639US2024287093A1High activity sting protein agonistADLAI NORTYE BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ADLAI NORTYE BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →